Search results
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 15 hours agoEli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals...
If I'm diagnosed with one cancer, am I likely to get another?
Medical Xpress· 3 days agoFear of cancer returning is one of the top health concerns. While initial cancer treatment may seem...
Drink this daily to protect the heart and lower blood pressure, experts say
Daily Express· 21 hours agoHeart health is a huge problem in the UK, with cardiovascular disease accounting for around a...
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
Medscape· 23 hours agoADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
FierceBiotech· 16 hours agoEli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to...
Safety institutes to form ‘international network’ to boost AI research and tests
Press Association News via AOL· 13 hours agoTen nations and the European Union have agreed to establish an international network of publicly...
IRE1α determines ferroptosis sensitivity through regulation of glutathione synthesis - Nature...
Nature· 7 days agoThe endoplasmic reticulum (ER) is a major site of lipid peroxidation during ferroptosis. Here authors show that the ER protein IRE1α determines ferroptosis induction via regulating glutathione synthesis independent of the unfolded protein response.
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 18 hours agoAmplifyBio and Xcell Biosciences have announced a strategic collaboration to advance the...
Plant Virus Fights Cancers in Mice With 'Widespread Effectiveness'
ScienceAlert via Yahoo News· 1 day agoA virus that infects black-eyed pea plants has shown "widespread effectiveness" in helping thwart an...
Researchers reveal promising treatment target for resistant brain cancer
Medical Xpress· 2 days agoAlthough temozolomide can initially slow tumor progression in some patients, typically the tumor cells rapidly become resistant to the drug. Working with glioblastoma cell cultures, including ...